pharmaceutical and medical preparations for the treatment of diseases, illnesses and ailments in humans and animals, namely: neurological diseases, na Read More

Classification Information

Class [005]
Pharmaceutical and medical preparations for the treatment of diseases, illnesses and ailments in humans and animals, namely: neurological diseases, namely Alzheimer's disease, Parkinson's disease, Huntington's disease, amyotrophic lateral sclerosis, dementia with Lewy bodies, Pick's disease, frontotemporal dementia, argyrophilic disease, progressive supranuclear palsy, fronto-temporal dementia, fronto-temporal dementia with parkinsonism linked to chromosome 17, disinhibition-dementia-parkinsonism-amyotrophy complex, pallido-ponto-nigral degeneration, Guam-ALS syndrome; pallido-nigro-luysian degeneration, cortico-basal degeneration, mild cognitive impairment (MCI), multiple system atrophy, drug-induced parkinsonism, and pure autonomic failure; psychiatric diseases, namely, schizophrenia, mood disorders, anxiety disorders, and cognitive disorders; neurological disorders, namely, mild cognitive impairment, tauopathies, and synucleinopathies; chemical preparations for medical and pharmaceutical purposes, namely for the treatment of diseases, illnesses and ailments in humans and animals, namely: neurological diseases, namely Alzheimer's disease, Parkinson's disease, Huntington's disease, amyotrophic lateral sclerosis, dementia with Lewy bodies, Pick's disease, frontotemporal dementia, argyrophilic disease, progressive supranuclear palsy, fronto-temporal dementia, fronto-temporal dementia with parkinsonism linked to chromosome 17, disinhibition-dementia-parkinsonism-amyotrophy complex, pallido-ponto-nigral degeneration, Guam-ALS syndrome; pallido-nigro-luysian degeneration, cortico-basal degeneration, mild cognitive impairment (MCI), multiple system atrophy, drug-induced parkinsonism, and pure autonomic failure; psychiatric diseases, namely, schizophrenia, mood disorders, anxiety disorders, and cognitive disorders; neurological disorders, namely, mild cognitive impairment, tauopathies, and synucleinopathies; pharmaceutical preparations and medical substances for use in relation to dementia

Classification kind code

Mark Details

Serial Number

1846329

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 50 on 10^th May 2019	Allowed
Submitted for opposition 51 on 10^th May 2019	Allowance Notice Sent
Submitted for opposition 42 on 23^rd Jan 2019	Advertised
Submitted for opposition 26 on 03^rd Jan 2019	Approved
Submitted for opposition 27 on 16^th Nov 2018	Approval Notice Sent
Submitted for opposition 22 on 18^th Jun 2018	Search Recorded
Submitted for opposition 20 on 18^th Jun 2018	Examiner's First Report
Submitted for opposition 31 on 11^th Jul 2017	Formalized
Submitted for opposition 1 on 10^th Jul 2017	Created
Submitted for opposition 30 on 07^th Jul 2017	Filed